Map Pharma (MAPP) Shares Now Down 30%
After an initial move slightly lower, shares of Map Pharma (Nasdaq: MAPP) are now down more than 30 percent in Tuesday's pre-open session. The last traded was at $11.50.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Fitbit (FIT) Remains Volatile, Retests Highs
- RCS Capital (RCAP) Files 8-K on Amendments with First- and Second-Lien Lenders
- Merkel says Greece unilaterally abandoned successful talks - Bloomberg
Create E-mail Alert Related CategoriesTrader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!